236 related articles for article (PubMed ID: 30194450)
1. VEGF
Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
[TBL] [Abstract][Full Text] [Related]
2. The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.
Abou Faycal C; Brambilla E; Agorreta J; Lepeltier N; Jacquet T; Lemaître N; Emadali A; Lucas A; Lacal PM; Montuenga L; Pio R; Gazzeri S; Eymin B
Br J Cancer; 2018 Jun; 118(12):1596-1608. PubMed ID: 29795310
[TBL] [Abstract][Full Text] [Related]
3. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
[TBL] [Abstract][Full Text] [Related]
4. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.
Wang Z; Liu T
Mol Cell Biochem; 2018 Feb; 439(1-2):163-169. PubMed ID: 28861767
[TBL] [Abstract][Full Text] [Related]
6. VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth.
Li X; Gu F; Niu C; Wang Y; Liu Z; Li N; Pan B; He D; Kong J; Zhang S; Wang X; Yao Y; Zheng L
J Transl Med; 2015 May; 13():164. PubMed ID: 25990504
[TBL] [Abstract][Full Text] [Related]
7. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
[TBL] [Abstract][Full Text] [Related]
8. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
9. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
Bates DO; MacMillan PP; Manjaly JG; Qiu Y; Hudson SJ; Bevan HS; Hunter AJ; Soothill PW; Read M; Donaldson LF; Harper SJ
Clin Sci (Lond); 2006 May; 110(5):575-85. PubMed ID: 16451124
[TBL] [Abstract][Full Text] [Related]
10. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.
Zygalaki E; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Aug; 53(8):1433-9. PubMed ID: 17599955
[TBL] [Abstract][Full Text] [Related]
11. A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma.
Montemagno C; Durivault J; Gastaldi C; Dufies M; Vial V; He X; Ambrosetti D; Kamenskaya A; Negrier S; Bernhard JC; Borchiellini D; Cao Y; Pagès G
Mol Oncol; 2023 Jul; 17(7):1379-1401. PubMed ID: 36810959
[TBL] [Abstract][Full Text] [Related]
12. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
13. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer.
Zhang X; Wang Y; Fan J; Chen W; Luan J; Mei X; Wang S; Li Y; Ye L; Li S; Tian W; Yin K; Ju D
J Immunother Cancer; 2019 Dec; 7(1):346. PubMed ID: 31829270
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor 165b expression in stromal cells and colorectal cancer.
Tayama M; Furuhata T; Inafuku Y; Okita K; Nishidate T; Mizuguchi T; Kimura Y; Hirata K
World J Gastroenterol; 2011 Nov; 17(44):4867-74. PubMed ID: 22171127
[TBL] [Abstract][Full Text] [Related]
16. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
[TBL] [Abstract][Full Text] [Related]
17. Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale.
Harris S; Craze M; Newton J; Fisher M; Shima DT; Tozer GM; Kanthou C
PLoS One; 2012; 7(5):e35231. PubMed ID: 22567098
[TBL] [Abstract][Full Text] [Related]
18. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
Hamdollah Zadeh MA; Amin EM; Hoareau-Aveilla C; Domingo E; Symonds KE; Ye X; Heesom KJ; Salmon A; D'Silva O; Betteridge KB; Williams AC; Kerr DJ; Salmon AH; Oltean S; Midgley RS; Ladomery MR; Harper SJ; Varey AH; Bates DO
Mol Oncol; 2015 Jan; 9(1):167-78. PubMed ID: 25224594
[TBL] [Abstract][Full Text] [Related]
20. How VEGF-A and its splice variants affect breast cancer development - clinical implications.
Al Kawas H; Saaid I; Jank P; Westhoff CC; Denkert C; Pross T; Weiler KBS; Karsten MM
Cell Oncol (Dordr); 2022 Apr; 45(2):227-239. PubMed ID: 35303290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
